Shpend Elezi

ORCID: 0000-0002-0426-0243
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Heart Failure Treatment and Management
  • Cardiovascular and exercise physiology
  • Cardiovascular Disease and Adiposity
  • Cardiac electrophysiology and arrhythmias
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac pacing and defibrillation studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Lipoproteins and Cardiovascular Health
  • Vascular Procedures and Complications
  • Adipokines, Inflammation, and Metabolic Diseases
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Effects of Exercise
  • Mechanical Circulatory Support Devices
  • Central Venous Catheters and Hemodialysis
  • Cardiac Health and Mental Health
  • Venous Thromboembolism Diagnosis and Management
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes
  • Platelet Disorders and Treatments
  • Peripheral Artery Disease Management

University Clinical Center of Kosovo
2008-2025

University of Prishtina
2010-2024

Albanian University
2019

University Clinical Centre
2005-2012

ING Direct
2011

Deutsches Herzzentrum München
1998-2006

Deutsches Herzzentrum der Charité
1997-2006

Technical University of Munich
1997-1999

Ludwig-Maximilians-Universität München
1999

Klinikum rechts der Isar
1998

Alec Vahanian Friedhelm Beyersdorf Fabien Praz Milan Milojevic Stephan Baldus and 95 more Johann Bauersachs Davide Capodanno Lenard Conradi Michele De Bonis Ruggero De Paulis Victoria Delgado Nick Freemantle Martine Gilard Kristina H. Haugaa Anders Jeppsson Peter Jüni Luc Piérard Bernard Prendergast Rafael Sádaba Christophe Tribouilloy Wojciech Wojakowski Franz‐Josef Neumann Patrick O. Myers Magdy Abdelhamid Stephan Achenbach Riccardo Asteggiano Fabio Barili Michael A. Borger Thierry Carrel Jean‐Philippe Collet Dan Foldager Gilbert Habib Christian Hassager Alar Irs Bernard Iung Marjan Jahangiri Hugo A. Katus Konstantinos C. Koskinas Steffen Massberg Christian Mueller Jens Cosedis Nielsen Philippe Pîbarot Amina Rakisheva Marco Roffi Andrea Rubboli Е. V. Shlyakhto Matthias Siepe Marta Sitges Lars Søndergaard Miguel Sousa‐Uva Guiseppe Tarantini José Luis Zamorano Fabien Praz Milan Milojevic Stephan Baldus Johann Bauersachs Davide Capodanno Lenard Conradi Michele De Bonis Ruggero De Paulis Victoria Delgado Nick Freemantle Martine Gilard Kristina H. Haugaa Anders Jeppsson Peter Jüni Luc Piérard Bernard Prendergast Rafael Sádaba Christophe Tribouilloy Wojciech Wojakowski Yasmina Benchabi A. L. Chilingaryan Bernhard Metzler Yasmin Rustamova Vadim Shumavets Patrizio Lancellotti Elnur Smajić Diana Trendafilova‐Lazarova Jure Samardžić Maria Karakyriou Tomáš Paleček Jordi S. Dahl Marwa Sayed Meshaal Kairit Palm Marko Virtanen Claire Bouleti Zviad Bakhutashvili Stephan Achenbach Maria Boutsikou Attila Kertész Ragnar Danielsen Yan Topilsky Paolo Golino Rustem Tuleutayev Shpend Elezi Alina Kerimkulov Ainārs Rudzītis Sigita Glaveckaitė Rouguiatou Sow

Guidelines •

10.1093/eurheartj/ehab395 article EN European Heart Journal 2021-06-11
Katja Zeppenfeld Jacob Tfelt‐Hansen Marta Riva Bo Gregers Winkel Elijah R. Behr and 95 more Nico A. Blom Philippe Charron Domenico Corrado Nikolaos Dagres Christian de Chillou Lars Eckardt Tim Friede Kristina H. Haugaa Mélèze Hocini Pier D. Lambiase Éloi Marijon José Luís Merino Petr Peichl Silvia G. Priori Tobias Reichlin Jeanette Schulz‐Menger Christian Sticherling Stylianos Tzeis Axel Verstrael Maurizio Volterrani Maja Čikeš Paulus Kirchhof Magdy Abdelhamid Victor Aboyans Elena Arbelo Fernando Arribas Riccardo Asteggiano Cristina Basso Axel Bauer Emanuele Bertaglia Tor Biering‐Sørensen C. Blomström‐Lundqvist Michael A. Borger Jelena Čelutkienė Bernard Cosyns Volkmar Falk Laurent Fauchier Bülent Görenek Sigrun Halvorsen Róbert Hatala Hein Heidbüchel Stefan Kääb А. О. Конради Konstantinos C. Koskinas Dipak Kotecha Ulf Landmesser Basil S. Lewis Aleš Linhart Maja Lisa Løchen Lars H. Lund Andreas Metzner Richard Mindham Jens Cosedis Nielsen Tone M Norekvål Monica Patten Eva Prescott Amina Rakisheva Carol Ann Remme Ivo Roca‐Luque Andrea Sarkozy Douglas S. Scherr Marta Sitges Rhian M. Touyz Nicolas M. Van Mieghem Vedran Velagić Sami Viskin Paul G.A. Volders B. Kichou Mihran Martirosyan Douglas S. Scherr Farid Aliyev Rik Willems Nabil Naser Tchavdar Shalganov Davor Miličić Theodoros Christophides Josef Kautzner J. P. Hart Hansen Lamyaa Allam Priit Kampus Juhani Junttila Christophe Leclercq Kakhaber Etsadashvili Daniel Steven Konstantinos Gatzoulis László Gellér Davíð O. Arnar Joseph Galvin Moti Haim Carlo Pappone Shpend Elezi Alina Kerimkulova Oskars Kalējs Ali Rabah Aras Puodžiūkynas

Vedran Velagic (Croatia), Sami Viskin (Israel)

10.1093/eurheartj/ehac262 article ET European Heart Journal 2022-08-26
Christiaan Vrints Felicita Andreotti Konstantinos C. Koskinas Xavier Rosselló Marianna Adamo and 95 more James Ainslie Adrian Banning Andrzej Budaj Ronny R. Buechel Giovanni Alfonso Chiariello Alaide Chieffo Ruxandra Christodorescu Christi Deaton Torsten Doenst Hywel Wynne Jones Vijay Kunadian Julinda Mehilli Milan Milojevic Jan J. Piek Francesca Pugliese Andrea Rubboli Anne Grete Semb Roxy Senior Jurriën M. ten Berg Éric Van Belle Emeline M. Van Craenenbroeck Rafael Vidal-Pérez Simon Winther Michael A. Borger Ingibjörg Guđmundsdóttir Juhani Knuuti Ingo Ahrens Michael Böhm Sergio Buccheri Davide Capodanno Evald Høj Christiansen Jean‐Philippe Collet Kenneth Dickstein Christian Eek Volkmar Falk Peter Henriksen Borja Ibáñez Stefan James Saško Kedev Lars Køber Martha Kyriakou Emma Magavern Angela McInerney John W. McEvoy Caius Ovidiu Mersha Borislava Mihaylova Richard Mindham Lis Neubeck Franz‐Josef Neumann Jens Cosedis Nielsen Pasquale Paolisso Valeria Paradies Agnès Pasquet Massimo Piepoli Eva Prescott Amina Rakisheva Bianca Rocca Marc Ruel Sigrid Sandner Antti Saraste Karolina Szummer Ilonca Vaartjes William Wijns Stephan Windecker Adam Witkowsky Marija Zdrakovic Katja Zeppenfeld Naltin Shuka Mohamed Abed Bouraghda Hamlet Hayrapetyan Sebastian J. Reinstadler Ogtay Musayev Michel De Pauw Zumreta Kušljugić Валери Гелев Boško Škorić Maria Karakyriou Tomáš Kovárník L H Nielsen Inas Mohamed Abdelaziz Tiia Ainla Pekka Porela Hakim Benamer Kakha Nadaraia Gert Richardt Michail I. Papafaklis Dávid Becker Ingibjörg Guđmundsdóttir Arik Wolak Carmine Riccio Bekbolat Zholdin Shpend Elezi S. Abilova Iveta Mintale Bachir Allam

10.1093/eurheartj/ehae177 article EN other-oa European Heart Journal 2024-08-30

The role of coronary stenting in the treatment patients with small vessels is not well defined. purpose this study was to investigate influence vessel size on long-term clinical and angiographic outcome after stent placement.The comprised 2602 successful implantation for symptomatic artery disease. Patients were subdivided into 3 equally sized groups (tertiles) according size, respective ranges <2.8, 2.8 3.2, >3.2 mm. Event-free survival at 1 year 69.5% group smaller vessels, 77.5% second...

10.1161/01.cir.98.18.1875 article EN Circulation 1998-11-03

Background —Our rationale for this study was to analyze the risk procedural failure of attempted stenting and major adverse cardiac events (MACE) after success develop a stratification protocol successful procedures. Methods Results —Stenting in 2894 procedures during 5-year period (success 98.3% 3815 lesions). After failure, MACE rate 42.6%. The higher lesions left circumflex coronary artery or venous bypass grafts an acute occlusion before stenting; it increased with stenosis length grade...

10.1161/01.cir.98.2.104 article EN Circulation 1998-07-14

Background —Platelets play a central role in the process of restenosis after percutaneous coronary interventions. A polymorphism platelet glycoprotein IIIa (Pl ) has been associated with higher risk thrombosis. We designed this prospective study to test hypothesis that Pl is an increased for stent placement. Methods and Results —The included 1150 consecutive patients successful placement 6-month follow-up angiography. The end point was incidence angiographic (≥50% diameter stenosis) at...

10.1161/01.cir.99.8.1005 article EN Circulation 1999-03-02

Background-The modified American College of Cardiology/American Heart Association (ACC/AHA) lesion morphology criteria are predictive early outcome after various coronary catheter interventions. Their potential prognostic value stent implantation and, in particular, for restenosis and long-term clinical has not been studied. We assessed the ACC/AHA angiographic patients stenting. Methods Results-This study includes 2944 consecutive with symptomatic artery disease treated placement. Modified...

10.1161/01.cir.100.12.1285 article EN Circulation 1999-09-21

The objective of this randomized trial was to assess whether differences in stent design are translated different clinical outcomes patients undergoing coronary placement. This multicenter included 1,147 who were randomly assigned receive one five types stainless steel stents: Inflow, MULTI-LINK, NIR, Palmaz-Schatz, and PURA-A stent. Primary endpoint the study event-free survival at 1 year. Event-free year significantly between groups (P = 0.014), ranging from 69.4% 82.4%. Similarly, freedom...

10.1002/1522-726x(200007)50:3<290::aid-ccd5>3.0.co;2-w article EN Catheterization and Cardiovascular Interventions 2000-01-01

Little is known about the behavior with regard to restenosis of multiple lesions within same patient treated intracoronary stenting. Our objective was test hypothesis that there an intrapatient dependence between lesions.Quantitative analysis carried out on angiograms obtained before, immediately after, and at 6 months after coronary stent placement in 1734 1244 patients. We used a specialized logistic regression not only accounts for intraclass correlation but also quantifies it form odds...

10.1161/01.cir.97.24.2396 article EN Circulation 1998-06-23

Background —High-pressure dilatation is considered a better stent placement strategy, but this has not yet been proved by appropriately designed studies. The objective of randomized trial was to assess the role high-pressure in early and late outcome patients undergoing coronary placement. Methods Results —Consecutive with were randomly assigned high- (15 20 atm, 468 patients) or low- (8 13 466 balloon-pressure dilatation. primary end point study event-free survival at 1 year. Secondary...

10.1161/01.cir.100.9.918 article EN Circulation 1999-08-31

The aim of this study was to assess the prevalence diastolic dysfunction left ventricle (LV) and right in patients with rheumatoid arthritis (RA) without clinically evident cardiovascular manifestations estimate whether there is a correlation between duration RA degree LV dysfunction. included 81 (61 females 20 males) heart disease (group 1) 40 healthy subjects (29 11 who served as control group 2). Both groups were matched for age sex. Echocardiographic Doppler studies conducted all...

10.1111/j.1368-5031.2006.00746.x article EN International Journal of Clinical Practice 2006-05-25

Abstract Introduction Cardiogenic shock (CS) complicates 3-13% of acute myocardial infarction (AMI) cases, with a mortality rate approximately 40% within the first 30 days, making it leading cause death in AMI patients. accounts for 81% CS cases. Pharmacological therapies, including inotropic agents vasoactive and vasopressor effects, are commonly administered these Purpose This study aimed to examine relationship between therapy patients post-AMI their outcomes. Methods We conducted...

10.1093/ehjacc/zuaf044.044 article EN European Heart Journal Acute Cardiovascular Care 2025-04-01

Abstract Introduction Cardiogenic shock (CS) complicates 3-13% of acute myocardial infarction (AMI) cases and carries a mortality rate roughly 40% within the first 30 days 50% year, making it leading cause death among AMI patients. Furthermore, is responsible for 81% CS cases. The pathophysiological mechanisms activated during contribute to alterations in several biochemical parameters, which may serve as crucial indicators identifying high-risk patients who develop CS. Purpose This study...

10.1093/ehjacc/zuaf044.031 article EN European Heart Journal Acute Cardiovascular Care 2025-04-01

Abstract Introduction Cardiogenic shock (CS) complicates acute myocardial infarction (AMI) in 3-13% of cases and has a mortality rate approximately 40% within the first 30 days 50% year, making it leading cause death AMI patients. accounts for 81% CS cases. Patients with elevated left ventricular end-diastolic pressure often present an S3 gallop, tachypnea, hypoxemia due to pulmonary edema, which may manifest lung rales. patients post-AMI hypotension, signs hypoperfusion such as oliguria or...

10.1093/ehjacc/zuaf044.055 article EN European Heart Journal Acute Cardiovascular Care 2025-04-01

The objective of this study was to assess the angiographic and clinical outcome patients with coronary in-stent restenosis treated balloon angioplasty provisional stenting. included 375 consecutive managed alone or combined Clinical events were recorded during a 1-year follow-up period quantitative analysis performed on 6-month data. Of 373 (451 lesions) successful procedure, 273 100 additional Target lesion revascularization required in 23.7% patients: 20.7% 31.0% Angiographic rate 38.9%:...

10.1002/(sici)1522-726x(199910)48:2<151::aid-ccd6>3.0.co;2-c article EN Catheterization and Cardiovascular Interventions 1999-10-01

Background Restenosis has been perceived as the tail end of a normal distribution response vessel to intervention. However, recent studies have described bimodal for de novo lesions after percutaneous transluminal coronary angioplasty. This finding suggests that some may be more susceptible restenosis. Whether this holds true wider spectrum undergoing stent placement is not yet known. The present study analyzes frequency angiographic indexes restenosis 6 months implantation. Methods and...

10.1161/01.cir.96.11.3880 article EN Circulation 1997-12-02

Abstract Introduction Cardiovascular complications commonly manifest after longstanding Type 2 Diabetes Mellitus. Newly diagnosed Mellitus (NDT2DM) is much less studied. The coronary artery computed tomography calcium score (CTCS) has become a widely accessible, accurate, and reliable tool for assessing the risk of major cardiovascular events, particularly in asymptomatic individuals. Additionally, myocardial strain, specifically echocardiographic Global Longitudinal Strain (GLS), measures...

10.1093/ehjci/jeae333.252 article EN European Heart Journal - Cardiovascular Imaging 2025-01-01

Abstract Introduction Newly diagnosed type 2 diabetes mellitus (NDT2DM) could be linked to cardiac complications. A multinational cohort of adults under 55 years old, who had acute myocardial infarction, showed NDT2DM in 14.5% patients. Timely diagnosis and treatment (DM) can help mitigate the risk long-term complications, particularly context ischemic heart disease. The computed tomography (CTCS) calcium score coronary arteries is a reliable predictor disease events. Echocardiography...

10.1093/ehjci/jeae333.477 article EN European Heart Journal - Cardiovascular Imaging 2025-01-01
Coming Soon ...